Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Details
<< Back to Results
Request Additional Trial InformationFull Trial Details: ClinicalTrials.gov
Condition: Breast Cancer Study Type: Interventional Phase: Phase II Study Start Date: 02/10/2015Study Completion Date: TBDAdditional Location(s): Washington Adventist Hospital
The purpose of this study is to determine if GTx-024 is effective and safe in the treatment of patients with advanced, androgen receptor positive triple negative breast cancer (AR+ TNBC).
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.